These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11695576)

  • 21. Regulatory Forum Opinion Piece*: Dispelling Confusing Pathology Terminology: Recognition and Interpretation of Selected Rodent Renal Tubule Lesions.
    Seely JC; Frazier KS
    Toxicol Pathol; 2015 Jun; 43(4):457-63. PubMed ID: 25869578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory forum opinion piece*: pathology peer review--to lock or not to lock, is that really the question?
    Engelhardt JA; Hardisty JF; Mann PC
    Toxicol Pathol; 2013; 41(7):1051-2. PubMed ID: 23960166
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathology peer review from the perspective of an external peer review pathologist.
    Mann PC
    Toxicol Pathol; 1996; 24(5):650-3. PubMed ID: 8923692
    [No Abstract]   [Full Text] [Related]  

  • 24. Study pathologist perspective of pathology peer review.
    Eighmy JJ
    Toxicol Pathol; 1996; 24(5):647-9. PubMed ID: 8923691
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma.
    Gopinath C; Mowat V
    Toxicol Pathol; 2019 Jul; 47(5):564-573. PubMed ID: 31291835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National Toxicology Program Position Statement on Informed ("Nonblinded") Analysis in Toxicologic Pathology Evaluation.
    Sills RC; Cesta MF; Willson CJ; Brix AE; Berridge BR
    Toxicol Pathol; 2019 Oct; 47(7):887-890. PubMed ID: 31522628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicologic Pathology Forum*: Opinion on Considerations for the Use of Whole Slide Images in GLP Pathology Peer Review.
    Bradley A; Jacobsen M
    Toxicol Pathol; 2019 Feb; 47(2):100-107. PubMed ID: 30636543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory forum opinion piece: blind reading of histopathology slides in general toxicology studies.
    Neef N; Nikula KJ; Francke-Carroll S; Boone L
    Toxicol Pathol; 2012 Jun; 40(4):697-9. PubMed ID: 22407309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the pathologist in GLP studies.
    Weber K; Hailey JR; Mann PC; Seaton M; Funk KA
    Toxicol Pathol; 2014 Jan; 42(1):275. PubMed ID: 24436040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives on pathology peer review.
    Long G
    Toxicol Pathol; 1996; 24(5):645-6. PubMed ID: 8923690
    [No Abstract]   [Full Text] [Related]  

  • 31. Spontaneous nonneoplastic lesions in control Syrian hamsters in three 24-month long-term carcinogenicity studies.
    McInnes EF; Ernst H; Germann PG
    Toxicol Pathol; 2015 Feb; 43(2):272-81. PubMed ID: 24771081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of diet, ad libitum overfeeding, and moderate dietary restriction on the rodent bioassay: the uncontrolled variable in safety assessment.
    Keenan KP; Laroque P; Ballam GC; Soper KA; Dixit R; Mattson BA; Adams SP; Coleman JB
    Toxicol Pathol; 1996; 24(6):757-68. PubMed ID: 8994307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Registry of toxicologic pathology for animals.
    Nold JB
    Toxicol Pathol; 1995; 23(5):622-3. PubMed ID: 8578106
    [No Abstract]   [Full Text] [Related]  

  • 34. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Progress to Date and Future Plans.
    Keenan CM; Baker J; Bradley A; Goodman DG; Harada T; Herbert R; Kaufmann W; Kellner R; Mahler B; Meseck E; Nolte T; Rittinghausen S; Vahle J; Yoshizawa K
    Toxicol Pathol; 2015 Jul; 43(5):730-2. PubMed ID: 25530274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory Forum commentary: through the looking glass--SENDing the pathology data we have INHAND.
    Keenan CM; Goodman DG
    Toxicol Pathol; 2014 Jul; 42(5):807-10. PubMed ID: 23599411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicologic Pathology Forum*: Commentary on "Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma".
    Patrick DJ; Troth SP
    Toxicol Pathol; 2019 Jul; 47(5):574-576. PubMed ID: 31303126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommended tissue list for histopathologic examination.
    Jacobs A; El Hage J; Hastings K; Jacobson-Kram D; Leighton J; Morse D
    Toxicol Pathol; 2003; 31(5):571. PubMed ID: 14692627
    [No Abstract]   [Full Text] [Related]  

  • 38. Overview of the "epigenetic end points in toxicologic pathology and relevance to human health" session of the 2014 Society Of Toxicologic Pathology Annual Symposium.
    Hoenerhoff MJ; Hartke J
    Toxicol Pathol; 2015 Jan; 43(1):98-100. PubMed ID: 25330923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Toxicol Pathol; 2009 Jun; 37(4):553-61. PubMed ID: 19458391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Exp Toxicol Pathol; 2010 Jul; 62(4):413-22. PubMed ID: 19604680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.